| 0 | 💬 0 |
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-07-10 | #immunotherapy #glioblastoma #checkpoint #t cell #oncology |